Best Prospects in the Interventional Oncology Devices Market and Strategies for Growth – Includes Interventional Oncology Devices Market Share
Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!
Major players in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Merit Medical Systems, Inc.
TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.
The interventional oncology devices market is expected to reach from $2.05 billion in 2021 to $2.82 billion in 2026 at a rate of 6.5%. The global interventional oncology devices market size is then expected to grow at a CAGR of 7.0% from 2026 and reach $3.97 billion in 2031.
North America was the largest region in the global interventional oncology devices market.
The interventional oncology devices market consists of the sale of interventional oncology devices and related services by entities (organizations, sole traders, and partnerships) that manufacture interventional oncology devices. Interventional oncology devices are used in the diagnosis and treatment of cancer, using targeted minimally invasive procedures, which help to destroy tumors without removing them.
Rising research and development spending in the medical sector is expected to fuel the interventional oncology devices market in the coming years.
Artificial intelligence (AI) is increasingly being used in cancer diagnosis and treatment. In interventional oncology, AI is used to identify imaging biomarkers to aid clinical decision-making capabilities and predict outcomes. AI can also help in standardizing and automating image interpretation and cancer detection.
TBRC’s Interventional Oncology Devices Market Report Is Segments:
By Product: Embolization Devices, Ablation Devices, Support Devices
By Procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE) or Bland Embolization
By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types
By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
The Interventional Oncology Devices Market Report 2022–Opportunities And Strategies – Global Forecast To 2031 is one of a series of new reports from The Business Research Company that provides an overview of the interventional oncology devices market globally and regionally, analyzes and forecasts market size, share, interventional oncology devices market players, interventional oncology devices market segments, leading competitor revenues, profiles and market shares.
Here Is A List Of Similar Reports From The Business Research Company:
Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: